Omega Fund Management »

Bridgebio Oncology Therapeut shares owned by Omega Fund Management

Quarter-by-quarter ownership of Bridgebio Oncology Therapeut shares owned by Omega Fund Management from 13F filings

Historical chart of Omega Fund Management investment in Bridgebio Oncology Therapeut

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Oncology Therapeut held by Omega Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Oncology Therapeut by Omega Fund Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $38M 3.3M 11.58

More positions owned by Omega Fund Management

Kestra Med Technologies Common Stock (KMTS)
Beta Bionics Common Stock (BBNX)
BridgeBio Oncology Therapeutics Common Stock
Bicara Therapeutics Common Stock (BCAX)
Nuvation Bio Common Stock Class A (NUVB)
Upstream Bio Common Stock (UPB)
ImageneBio Common Stock
enGene Holdings Common Stock (ENGN)
Sana Biotechnology Common Stock (SANA)
Alumis Common Stock (ALMS)
Replimune Group Common Stock (REPL)
enGene Holdings Warrant (ENGNW)

View all positions for Omega Fund Management

Top funds holding Bridgebio Oncology Therapeut

Cormorant Asset Management
Deerfield Management Company
Omega Fund Management
Wellington Management Company
Alphabet
EcoR1 Capital
Enavate Sciences GP
Citadel Advisors
BlackRock
Novo A/S
Paradigm Biocapital Advisors
Adage Capital Partners GP
Eventide Asset Management
Laurion Capital Management
Octagon Capital Advisors

View all funds holding Bridgebio Oncology Therapeut